Stocks · Health care · Pharmaceutical Preparations

Equillium, Inc.

EQ Clue Score53
United States Fiscal year ends December CIK 0001746466 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Penny Tom
8 Jan 2026
Principal Accounting Officer
Sold on a plan
6,533
$1.29
$8.43K
Christine Zedelmayer
15 Dec 2025
Sr. Vice President and COO
Sold on a plan
11,900
$1.31
$15.59K
Christine Zedelmayer
12 Dec 2025
Sr. Vice President and COO
Sold on a plan
23,804
$1.34
$31.90K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
7,998
$0.95
$7.60K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
100
$0.98
$98.00
Jason A Keyes
23 Jan 2025
Chief Financial Officer
Sold on a plan indirect
10,000
$0.65
$6.50K
Jason A Keyes
14 Nov 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.70
$7.00K
Penny Tom
28 Oct 2024
Principal Accounting Officer
Sold on a plan
2,835
$1.25
$3.54K
Christine Zedelmayer
28 Oct 2024
Sr. Vice President and COO
Sold on a plan
15,000
$1.25
$18.75K
Penny Tom
25 Oct 2024
Principal Accounting Officer
Sold on a plan
683
$1.25
$853.75
Jason A Keyes
26 Sep 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.81
$8.10K
Penny Tom
16 Sep 2024
Principal Accounting Officer
Sold on a plan
38,806
$0.85
$32.99K
Jason A Keyes
16 Jul 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.87
$8.70K

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 20
Sales at will 17
Transactions with no price 1
Shares from compensation/vesting 1,297,109
Sales filed before the plan box existed 15
History held since 16 Oct 2018